65 related articles for article (PubMed ID: 582916)
1. Antiulcerogenic effect of a pyrido-benzodiazepine derivative (L-S 519) on experimental ulcers.
Kitagawa H; Kurahashi K; Fujiwara M; Kohei H
Arzneimittelforschung; 1978; 28(11):2122-7. PubMed ID: 582916
[TBL] [Abstract][Full Text] [Related]
2. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
3. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
Okabe S; Tabata K; Kawakami M
Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
[TBL] [Abstract][Full Text] [Related]
5. The influence of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016) on gastric ulcer and gastric acid secretion.
Tobe A; Yoshida Y; Egawa M
Arzneimittelforschung; 1983; 33(3):397-400. PubMed ID: 6683513
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
7. Effect of some Sitavirya drugs on gastric secretion and ulceration.
De B; Maiti RN; Joshi VK; Agrawal VK; Goel RK
Indian J Exp Biol; 1997 Oct; 35(10):1084-7. PubMed ID: 9475045
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric ulcers and gastric secretion in experimental animals.
Ueda F; Aratani S; Mimura K; Kimura K; Nomura A; Enomoto H
Arzneimittelforschung; 1984; 34(4):474-7. PubMed ID: 6540106
[TBL] [Abstract][Full Text] [Related]
9. Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer.
Matsuo Y; Seki A
Arzneimittelforschung; 1979; 29(7):1028-35. PubMed ID: 582994
[No Abstract] [Full Text] [Related]
10. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
DiJoseph JF; Eash JR; Mir GN
J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
[TBL] [Abstract][Full Text] [Related]
11. Gastric anti-ulcer and cytoprotective effect of l-serine in rats.
Tariq M; Al Moutaery AR
Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):171-84. PubMed ID: 9344230
[TBL] [Abstract][Full Text] [Related]
12. Anti-gastric acid secretory mechanism of 1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarboxylic acid. Effect on mucosal mast cell.
Ishizuka Y; Kamisaki T; Sato M
Arzneimittelforschung; 1996 Sep; 46(9):919-22. PubMed ID: 8876942
[TBL] [Abstract][Full Text] [Related]
13. Gastric cytoprotection by pirenzepine is not mediated by catecholamines.
Martinotti E; Bernardini C; Del Tacca M; Pellegrini M; Soldani G; Bertelli A
Acta Physiol Hung; 1984; 64(3-4):219-24. PubMed ID: 6549422
[TBL] [Abstract][Full Text] [Related]
14. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
15. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
16. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine, a new non-anticholinergic gastric antisecretory agent.
Bianchetti A; Guarneri L; Biraschi LM; Riva M
Arzneimittelforschung; 1975 Apr; 25(4):580-9. PubMed ID: 239733
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of the inhibition of gastric secretion produced by esophageal ligation in the pylorus-ligated rat.
Brodie DA; Knapp PG
Gastroenterology; 1966 Jun; 50(6):787-95. PubMed ID: 5212380
[TBL] [Abstract][Full Text] [Related]
19. Gastric antisecretory and antiulcer effects of simvastatin in rats.
Tariq M; Khan HA; Elfaki I; Arshaduddin M; Al Moutaery M; Al Rayes H; Al Swailam R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2316-23. PubMed ID: 17593225
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
